 Duncan Wilcox
Concepts (545)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 27 | 2024 | 183 | 4.940 |
Why?
| | Cloaca | 18 | 2023 | 48 | 3.560 |
Why?
| | Urologic Surgical Procedures | 19 | 2025 | 120 | 3.100 |
Why?
| | Hypospadias | 7 | 2022 | 29 | 2.790 |
Why?
| | Urinary Bladder Neck Obstruction | 5 | 2023 | 21 | 2.270 |
Why?
| | Urogenital Abnormalities | 10 | 2023 | 64 | 2.210 |
Why?
| | Anorectal Malformations | 10 | 2024 | 112 | 1.890 |
Why?
| | Urinary Bladder, Neurogenic | 6 | 2024 | 38 | 1.880 |
Why?
| | Urethra | 11 | 2020 | 55 | 1.820 |
Why?
| | Urodynamics | 7 | 2025 | 44 | 1.800 |
Why?
| | Lower Urinary Tract Symptoms | 6 | 2024 | 60 | 1.770 |
Why?
| | Hydronephrosis | 7 | 2015 | 36 | 1.590 |
Why?
| | Urology | 8 | 2024 | 63 | 1.440 |
Why?
| | Urogenital System | 4 | 2023 | 17 | 1.430 |
Why?
| | Spinal Dysraphism | 7 | 2025 | 90 | 1.390 |
Why?
| | Ureteral Obstruction | 5 | 2022 | 64 | 1.290 |
Why?
| | Urinary Bladder, Overactive | 2 | 2021 | 22 | 1.270 |
Why?
| | Hirschsprung Disease | 9 | 2024 | 88 | 1.070 |
Why?
| | Circumcision, Male | 2 | 2019 | 14 | 1.060 |
Why?
| | Kidney | 13 | 2023 | 1468 | 1.050 |
Why?
| | Lactams, Macrocyclic | 2 | 2017 | 49 | 1.020 |
Why?
| | Benzoquinones | 2 | 2017 | 48 | 1.020 |
Why?
| | Urologic Surgical Procedures, Male | 3 | 2022 | 30 | 1.020 |
Why?
| | Postoperative Complications | 20 | 2024 | 2654 | 1.010 |
Why?
| | Urinary Tract | 5 | 2016 | 51 | 0.990 |
Why?
| | Infant | 50 | 2024 | 9465 | 0.980 |
Why?
| | Hernias, Diaphragmatic, Congenital | 15 | 1998 | 201 | 0.950 |
Why?
| | Pain, Postoperative | 4 | 2020 | 265 | 0.910 |
Why?
| | Hernia, Diaphragmatic | 13 | 2000 | 65 | 0.900 |
Why?
| | Urinary Incontinence | 6 | 2015 | 66 | 0.890 |
Why?
| | Child | 66 | 2025 | 21935 | 0.880 |
Why?
| | Child, Preschool | 46 | 2025 | 11074 | 0.840 |
Why?
| | Reoperation | 11 | 2018 | 573 | 0.840 |
Why?
| | Male | 95 | 2025 | 67762 | 0.830 |
Why?
| | Tocotrienols | 1 | 2023 | 3 | 0.820 |
Why?
| | Cryptorchidism | 5 | 2024 | 15 | 0.810 |
Why?
| | Urination | 4 | 2022 | 45 | 0.810 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 243 | 0.810 |
Why?
| | Urologic Diseases | 5 | 2018 | 41 | 0.800 |
Why?
| | Ureter | 6 | 2019 | 36 | 0.790 |
Why?
| | Fecal Incontinence | 7 | 2025 | 86 | 0.770 |
Why?
| | Postoperative Care | 3 | 2019 | 261 | 0.760 |
Why?
| | Muscle, Smooth | 4 | 2017 | 155 | 0.760 |
Why?
| | Rectum | 7 | 2023 | 185 | 0.750 |
Why?
| | Penis | 3 | 2019 | 36 | 0.750 |
Why?
| | Humans | 146 | 2025 | 137585 | 0.750 |
Why?
| | Urinary Bladder Diseases | 4 | 2022 | 19 | 0.740 |
Why?
| | Disorders of Sex Development | 2 | 2019 | 39 | 0.720 |
Why?
| | Kidney Pelvis | 4 | 2022 | 24 | 0.710 |
Why?
| | Anger | 1 | 2021 | 60 | 0.710 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2021 | 20 | 0.700 |
Why?
| | Cystostomy | 3 | 2017 | 9 | 0.690 |
Why?
| | Anal Canal | 6 | 2023 | 97 | 0.690 |
Why?
| | TRPV Cation Channels | 1 | 2021 | 40 | 0.680 |
Why?
| | Calcium Channels | 1 | 2021 | 159 | 0.650 |
Why?
| | Female | 89 | 2025 | 73304 | 0.650 |
Why?
| | Constipation | 1 | 2021 | 94 | 0.640 |
Why?
| | Retrospective Studies | 46 | 2025 | 15657 | 0.630 |
Why?
| | Ultrasonography, Prenatal | 8 | 2014 | 285 | 0.610 |
Why?
| | Follow-Up Studies | 23 | 2018 | 5131 | 0.610 |
Why?
| | Laparoscopy | 7 | 2024 | 466 | 0.610 |
Why?
| | Receptors, Purinergic P2X1 | 1 | 2018 | 3 | 0.600 |
Why?
| | Cholinergic Fibers | 1 | 2018 | 18 | 0.590 |
Why?
| | Receptors, Muscarinic | 1 | 2018 | 19 | 0.590 |
Why?
| | Photography | 1 | 2019 | 96 | 0.590 |
Why?
| | Intestine, Large | 1 | 2018 | 14 | 0.580 |
Why?
| | Genitalia, Female | 2 | 2018 | 38 | 0.580 |
Why?
| | Muscle Contraction | 3 | 2019 | 424 | 0.570 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2012 | 32 | 0.570 |
Why?
| | Anesthetics, Local | 2 | 2015 | 80 | 0.550 |
Why?
| | Urination Disorders | 2 | 2015 | 13 | 0.540 |
Why?
| | Vagina | 3 | 2023 | 187 | 0.540 |
Why?
| | Preoperative Care | 3 | 2011 | 362 | 0.540 |
Why?
| | Pulmonary Surfactants | 9 | 2000 | 106 | 0.530 |
Why?
| | Treatment Outcome | 24 | 2025 | 10811 | 0.520 |
Why?
| | Perioperative Care | 2 | 2018 | 178 | 0.520 |
Why?
| | Bladder Exstrophy | 6 | 2007 | 17 | 0.510 |
Why?
| | Clitoris | 1 | 2016 | 9 | 0.500 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2015 | 3 | 0.480 |
Why?
| | Infant, Newborn | 28 | 2020 | 6079 | 0.470 |
Why?
| | Surgical Wound Infection | 2 | 2025 | 307 | 0.470 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2011 | 36 | 0.460 |
Why?
| | Nephrectomy | 5 | 2009 | 169 | 0.440 |
Why?
| | Vincristine | 3 | 2024 | 116 | 0.430 |
Why?
| | Infusion Pumps | 1 | 2013 | 32 | 0.430 |
Why?
| | Gastrointestinal Diseases | 1 | 2016 | 209 | 0.430 |
Why?
| | Prospective Studies | 15 | 2025 | 7604 | 0.430 |
Why?
| | Recovery of Function | 1 | 2018 | 653 | 0.420 |
Why?
| | Colon | 4 | 2023 | 282 | 0.420 |
Why?
| | Creatinine | 1 | 2015 | 499 | 0.410 |
Why?
| | Pediatrics | 4 | 2024 | 1101 | 0.400 |
Why?
| | Animals | 30 | 2024 | 36940 | 0.400 |
Why?
| | Adolescent | 41 | 2025 | 21513 | 0.400 |
Why?
| | Paraphimosis | 1 | 2012 | 1 | 0.390 |
Why?
| | Enema | 2 | 2006 | 47 | 0.390 |
Why?
| | Abnormalities, Multiple | 5 | 2006 | 189 | 0.390 |
Why?
| | Bandages | 1 | 2012 | 37 | 0.380 |
Why?
| | Cadherins | 1 | 2014 | 206 | 0.380 |
Why?
| | Diagnostic Techniques, Urological | 1 | 2012 | 5 | 0.380 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 278 | 0.380 |
Why?
| | Radioisotope Renography | 1 | 2011 | 4 | 0.370 |
Why?
| | Edema | 1 | 2012 | 130 | 0.360 |
Why?
| | Incidence | 7 | 2024 | 2804 | 0.360 |
Why?
| | Surgical Sponges | 1 | 2011 | 4 | 0.360 |
Why?
| | Age Factors | 9 | 2019 | 3295 | 0.360 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 1000 | 0.360 |
Why?
| | Dissection | 1 | 2011 | 52 | 0.350 |
Why?
| | Guideline Adherence | 1 | 2015 | 556 | 0.340 |
Why?
| | Stents | 1 | 2014 | 527 | 0.340 |
Why?
| | Transition to Adult Care | 2 | 2023 | 91 | 0.320 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5757 | 0.320 |
Why?
| | Registries | 1 | 2018 | 2035 | 0.320 |
Why?
| | Sexual Dysfunction, Physiological | 2 | 2009 | 64 | 0.310 |
Why?
| | Disease Models, Animal | 10 | 2018 | 4295 | 0.310 |
Why?
| | Wilms Tumor | 3 | 2017 | 86 | 0.310 |
Why?
| | Prenatal Diagnosis | 6 | 2007 | 201 | 0.310 |
Why?
| | Fetal Diseases | 3 | 2007 | 173 | 0.310 |
Why?
| | Cystitis | 1 | 2009 | 22 | 0.310 |
Why?
| | Neurosurgical Procedures | 1 | 2011 | 197 | 0.310 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 617 | 0.310 |
Why?
| | Urethral Diseases | 3 | 2020 | 19 | 0.300 |
Why?
| | Doxorubicin | 2 | 2021 | 362 | 0.290 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2011 | 545 | 0.290 |
Why?
| | Mice | 13 | 2024 | 17787 | 0.290 |
Why?
| | Ileum | 2 | 2006 | 119 | 0.290 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2005 | 37 | 0.290 |
Why?
| | Ureterocele | 1 | 2007 | 7 | 0.290 |
Why?
| | Signal Transduction | 2 | 2021 | 5079 | 0.280 |
Why?
| | Pulmonary Gas Exchange | 4 | 1998 | 121 | 0.280 |
Why?
| | Digestive System Abnormalities | 2 | 2004 | 21 | 0.280 |
Why?
| | Robotic Surgical Procedures | 2 | 2022 | 130 | 0.270 |
Why?
| | Colon, Sigmoid | 5 | 2021 | 20 | 0.260 |
Why?
| | Urography | 1 | 2006 | 17 | 0.260 |
Why?
| | Cathartics | 1 | 2006 | 15 | 0.260 |
Why?
| | Urinary Bladder Fistula | 2 | 2022 | 10 | 0.260 |
Why?
| | Congenital Abnormalities | 3 | 2020 | 92 | 0.250 |
Why?
| | Vesicovaginal Fistula | 1 | 2005 | 4 | 0.250 |
Why?
| | Kidney Function Tests | 4 | 2015 | 160 | 0.240 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2025 | 27 | 0.230 |
Why?
| | Pain Measurement | 3 | 2015 | 521 | 0.230 |
Why?
| | Animals, Newborn | 6 | 2018 | 844 | 0.230 |
Why?
| | Colorectal Neoplasms | 2 | 2022 | 806 | 0.230 |
Why?
| | Postnatal Care | 2 | 2015 | 71 | 0.220 |
Why?
| | Orchiopexy | 2 | 2024 | 6 | 0.220 |
Why?
| | Hemorrhage | 1 | 2009 | 722 | 0.220 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2004 | 57 | 0.220 |
Why?
| | Kidney Neoplasms | 2 | 2009 | 403 | 0.220 |
Why?
| | Psychosocial Support Systems | 1 | 2023 | 12 | 0.210 |
Why?
| | Endometriosis | 1 | 2024 | 51 | 0.210 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2022 | 128 | 0.210 |
Why?
| | Urinary Diversion | 4 | 2015 | 12 | 0.210 |
Why?
| | Mass Screening | 1 | 2012 | 1287 | 0.210 |
Why?
| | Fetus | 1 | 2007 | 806 | 0.200 |
Why?
| | Prognosis | 5 | 2018 | 4030 | 0.200 |
Why?
| | Propensity Score | 1 | 2024 | 294 | 0.200 |
Why?
| | Sacrum | 1 | 2003 | 67 | 0.200 |
Why?
| | Imaging, Three-Dimensional | 1 | 2006 | 580 | 0.190 |
Why?
| | Delphi Technique | 1 | 2024 | 280 | 0.190 |
Why?
| | Length of Stay | 5 | 2023 | 1215 | 0.190 |
Why?
| | Surgical Flaps | 1 | 2003 | 130 | 0.190 |
Why?
| | Ultrasonography | 4 | 2015 | 759 | 0.190 |
Why?
| | Risk Assessment | 6 | 2024 | 3457 | 0.190 |
Why?
| | Muscle Development | 1 | 2003 | 111 | 0.190 |
Why?
| | Lung | 6 | 1998 | 4060 | 0.190 |
Why?
| | Kidney Calices | 1 | 2001 | 1 | 0.190 |
Why?
| | Analgesia | 2 | 2020 | 94 | 0.190 |
Why?
| | Cell Hypoxia | 3 | 2014 | 226 | 0.180 |
Why?
| | Consensus | 2 | 2024 | 683 | 0.180 |
Why?
| | Spinal Cord Injuries | 1 | 2025 | 212 | 0.180 |
Why?
| | Sheep | 11 | 1998 | 856 | 0.180 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 153 | 0.180 |
Why?
| | Pilot Projects | 3 | 2025 | 1710 | 0.180 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 106 | 0.180 |
Why?
| | Catheterization | 3 | 2013 | 179 | 0.180 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 350 | 0.180 |
Why?
| | Sex Factors | 5 | 2024 | 2071 | 0.180 |
Why?
| | Testicular Neoplasms | 2 | 2019 | 110 | 0.180 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2020 | 16 | 0.170 |
Why?
| | Pregnancy Outcome | 2 | 2022 | 416 | 0.170 |
Why?
| | Robotics | 1 | 2022 | 94 | 0.170 |
Why?
| | Hydrocephalus | 2 | 2011 | 106 | 0.170 |
Why?
| | Administration, Oral | 1 | 2023 | 816 | 0.170 |
Why?
| | Gastrostomy | 2 | 1999 | 117 | 0.170 |
Why?
| | Intestinal Obstruction | 3 | 1997 | 51 | 0.170 |
Why?
| | Prune Belly Syndrome | 2 | 2011 | 8 | 0.170 |
Why?
| | Colitis, Ulcerative | 2 | 2021 | 136 | 0.160 |
Why?
| | Cell Division | 1 | 2002 | 794 | 0.160 |
Why?
| | Perinatology | 1 | 1999 | 11 | 0.160 |
Why?
| | Hypertrophy | 2 | 2019 | 133 | 0.160 |
Why?
| | Smooth Muscle Myosins | 1 | 2019 | 6 | 0.160 |
Why?
| | Reflex | 2 | 2018 | 68 | 0.160 |
Why?
| | Muscle Relaxation | 1 | 2019 | 19 | 0.160 |
Why?
| | Myosin Light Chains | 1 | 2019 | 26 | 0.160 |
Why?
| | Atlases as Topic | 1 | 2019 | 10 | 0.160 |
Why?
| | Nephrostomy, Percutaneous | 1 | 1999 | 9 | 0.150 |
Why?
| | Emotions | 1 | 2024 | 548 | 0.150 |
Why?
| | Nephrology Nursing | 1 | 2019 | 14 | 0.150 |
Why?
| | Nephrology | 1 | 1999 | 61 | 0.150 |
Why?
| | Pediatric Nursing | 1 | 2019 | 42 | 0.150 |
Why?
| | Anxiety, Separation | 1 | 2018 | 16 | 0.150 |
Why?
| | Maternal Deprivation | 1 | 2018 | 16 | 0.150 |
Why?
| | Twins, Conjoined | 1 | 1998 | 5 | 0.150 |
Why?
| | Umbilicus | 1 | 1998 | 18 | 0.150 |
Why?
| | Extracellular Matrix | 1 | 2003 | 528 | 0.150 |
Why?
| | Diet | 1 | 2006 | 1278 | 0.150 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 127 | 0.150 |
Why?
| | Phospholipids | 2 | 1997 | 223 | 0.140 |
Why?
| | Young Adult | 10 | 2025 | 13209 | 0.140 |
Why?
| | Diagnostic Errors | 1 | 2019 | 170 | 0.140 |
Why?
| | Glomerular Filtration Rate | 3 | 2015 | 746 | 0.140 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 1997 | 9 | 0.140 |
Why?
| | Reference Values | 2 | 2018 | 816 | 0.140 |
Why?
| | Medical Errors | 1 | 2019 | 112 | 0.140 |
Why?
| | Kidney Diseases | 4 | 2009 | 408 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 160 | 0.140 |
Why?
| | Phosphatidylcholines | 2 | 1997 | 147 | 0.140 |
Why?
| | Urinary Catheterization | 2 | 2001 | 33 | 0.140 |
Why?
| | Genitalia, Male | 1 | 1997 | 11 | 0.140 |
Why?
| | Genitalia | 3 | 2019 | 30 | 0.140 |
Why?
| | Time Factors | 6 | 2019 | 6828 | 0.140 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 31 | 0.140 |
Why?
| | Informed Consent | 1 | 1998 | 175 | 0.140 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1997 | 4 | 0.140 |
Why?
| | Peptic Ulcer Hemorrhage | 1 | 1997 | 6 | 0.130 |
Why?
| | Peptic Ulcer Perforation | 1 | 1997 | 4 | 0.130 |
Why?
| | Duodenal Ulcer | 1 | 1997 | 13 | 0.130 |
Why?
| | Decision Making | 1 | 2024 | 900 | 0.130 |
Why?
| | Case-Control Studies | 3 | 2020 | 3556 | 0.130 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 273 | 0.130 |
Why?
| | Cholelithiasis | 1 | 1997 | 38 | 0.130 |
Why?
| | Gallstones | 1 | 1997 | 33 | 0.130 |
Why?
| | Adult | 17 | 2024 | 37929 | 0.130 |
Why?
| | Postoperative Period | 1 | 2018 | 342 | 0.130 |
Why?
| | Algorithms | 3 | 2018 | 1704 | 0.130 |
Why?
| | Caregivers | 1 | 2024 | 877 | 0.130 |
Why?
| | Cancer Survivors | 1 | 2021 | 285 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 815 | 0.130 |
Why?
| | Vulva | 1 | 2016 | 24 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1774 | 0.120 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2017 | 252 | 0.120 |
Why?
| | Fluorocarbons | 1 | 1997 | 117 | 0.120 |
Why?
| | Patient Safety | 1 | 2019 | 314 | 0.120 |
Why?
| | Endoscopy | 1 | 1998 | 318 | 0.120 |
Why?
| | Pneumothorax | 1 | 1995 | 38 | 0.120 |
Why?
| | Phosphatidylglycerols | 1 | 1995 | 24 | 0.120 |
Why?
| | Outpatients | 1 | 2019 | 396 | 0.120 |
Why?
| | Sphingomyelins | 1 | 1995 | 33 | 0.120 |
Why?
| | Pregnancy | 11 | 2022 | 6763 | 0.120 |
Why?
| | Infusion Pumps, Implantable | 1 | 2015 | 25 | 0.120 |
Why?
| | Toothbrushing | 1 | 1994 | 5 | 0.120 |
Why?
| | Risk Factors | 3 | 2018 | 10388 | 0.120 |
Why?
| | Surveys and Questionnaires | 6 | 2024 | 5778 | 0.120 |
Why?
| | Testis | 2 | 2023 | 151 | 0.120 |
Why?
| | Lung Compliance | 2 | 1995 | 49 | 0.120 |
Why?
| | Attitude to Health | 1 | 1998 | 439 | 0.120 |
Why?
| | Gynecologic Surgical Procedures | 3 | 2021 | 63 | 0.120 |
Why?
| | Medical Oncology | 1 | 2017 | 289 | 0.110 |
Why?
| | Bulimia | 1 | 1994 | 25 | 0.110 |
Why?
| | Desmin | 2 | 2006 | 24 | 0.110 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1509 | 0.110 |
Why?
| | Appendix | 3 | 2001 | 30 | 0.110 |
Why?
| | Amniotic Fluid | 1 | 1995 | 96 | 0.110 |
Why?
| | Triiodothyronine | 1 | 1994 | 43 | 0.110 |
Why?
| | Scrotum | 2 | 2007 | 27 | 0.110 |
Why?
| | Bone and Bones | 1 | 1997 | 317 | 0.110 |
Why?
| | Laparotomy | 1 | 1994 | 109 | 0.110 |
Why?
| | Organ Size | 2 | 2014 | 477 | 0.110 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 1946 | 0.110 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 431 | 0.110 |
Why?
| | Meconium | 1 | 1993 | 7 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2002 | 1991 | 0.110 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 413 | 0.110 |
Why?
| | ROC Curve | 2 | 2015 | 554 | 0.110 |
Why?
| | Phenyl Ethers | 1 | 1993 | 4 | 0.100 |
Why?
| | Foreign Bodies | 1 | 1994 | 104 | 0.100 |
Why?
| | Anastomosis, Surgical | 5 | 2020 | 153 | 0.100 |
Why?
| | Foreign-Body Migration | 2 | 2011 | 34 | 0.100 |
Why?
| | Perineum | 2 | 2019 | 32 | 0.100 |
Why?
| | Logistic Models | 1 | 2018 | 2074 | 0.100 |
Why?
| | Nitric Oxide | 2 | 1997 | 915 | 0.100 |
Why?
| | Respiration, Artificial | 1 | 1997 | 645 | 0.100 |
Why?
| | Foreskin | 1 | 2012 | 6 | 0.100 |
Why?
| | Apoptosis | 1 | 2002 | 2553 | 0.100 |
Why?
| | Syndrome | 2 | 2007 | 358 | 0.100 |
Why?
| | Infant Food | 1 | 1993 | 65 | 0.100 |
Why?
| | Fertility | 2 | 2022 | 160 | 0.100 |
Why?
| | Epispadias | 2 | 2002 | 4 | 0.100 |
Why?
| | Comorbidity | 2 | 2016 | 1622 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 209 | 0.090 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2011 | 3 | 0.090 |
Why?
| | Fetal Blood | 1 | 1994 | 327 | 0.090 |
Why?
| | Hydrocortisone | 1 | 1994 | 322 | 0.090 |
Why?
| | Metabolism, Inborn Errors | 1 | 2011 | 41 | 0.090 |
Why?
| | Shock | 1 | 1993 | 98 | 0.090 |
Why?
| | Gestational Age | 4 | 2004 | 910 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2828 | 0.090 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 565 | 0.090 |
Why?
| | Pain Management | 1 | 2013 | 352 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 2031 | 0.080 |
Why?
| | Hernia, Ventral | 1 | 2010 | 24 | 0.080 |
Why?
| | Parents | 1 | 1998 | 1347 | 0.080 |
Why?
| | Ischemia | 1 | 1993 | 409 | 0.080 |
Why?
| | Genetic Therapy | 1 | 2011 | 297 | 0.080 |
Why?
| | Acute Disease | 1 | 2012 | 1007 | 0.080 |
Why?
| | Intestines | 3 | 2020 | 357 | 0.080 |
Why?
| | Urinary Reservoirs, Continent | 2 | 2016 | 4 | 0.080 |
Why?
| | Campomelic Dysplasia | 1 | 2009 | 2 | 0.080 |
Why?
| | Dysgerminoma | 1 | 2009 | 6 | 0.080 |
Why?
| | BK Virus | 1 | 2009 | 17 | 0.080 |
Why?
| | Databases, Factual | 3 | 2019 | 1357 | 0.080 |
Why?
| | Urolithiasis | 1 | 2009 | 9 | 0.080 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1738 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 622 | 0.080 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 245 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 1 | 2009 | 39 | 0.080 |
Why?
| | SOX9 Transcription Factor | 1 | 2009 | 24 | 0.080 |
Why?
| | Tumor Virus Infections | 1 | 2009 | 49 | 0.080 |
Why?
| | Polyomavirus Infections | 1 | 2009 | 31 | 0.080 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 1997 | 652 | 0.070 |
Why?
| | Ureterostomy | 1 | 2007 | 3 | 0.070 |
Why?
| | Cohort Studies | 2 | 2016 | 5742 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 286 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 740 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.070 |
Why?
| | Urogenital Neoplasms | 1 | 2006 | 5 | 0.070 |
Why?
| | Myogenin | 1 | 2006 | 16 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 156 | 0.070 |
Why?
| | Calcinosis | 1 | 2009 | 235 | 0.070 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2006 | 22 | 0.060 |
Why?
| | Pulmonary Artery | 4 | 1997 | 1086 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2009 | 1316 | 0.060 |
Why?
| | Neoplasms | 1 | 2021 | 2671 | 0.060 |
Why?
| | Hematocolpos | 1 | 2005 | 3 | 0.060 |
Why?
| | Nanoparticles | 1 | 2011 | 481 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2007 | 258 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2011 | 786 | 0.060 |
Why?
| | Fetal Organ Maturity | 2 | 1995 | 27 | 0.060 |
Why?
| | Malabsorption Syndromes | 1 | 2004 | 16 | 0.060 |
Why?
| | Defecation | 1 | 2004 | 19 | 0.060 |
Why?
| | Gonadoblastoma | 1 | 2024 | 6 | 0.060 |
Why?
| | Nutritional Support | 1 | 2004 | 34 | 0.060 |
Why?
| | Menstruation Disturbances | 1 | 2003 | 13 | 0.050 |
Why?
| | Salvage Therapy | 1 | 2004 | 142 | 0.050 |
Why?
| | Coitus | 1 | 2003 | 22 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1587 | 0.050 |
Why?
| | Urologists | 1 | 2023 | 17 | 0.050 |
Why?
| | Rabbits | 2 | 1996 | 794 | 0.050 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2003 | 30 | 0.050 |
Why?
| | Urethral Obstruction | 1 | 2003 | 9 | 0.050 |
Why?
| | Decision Support Techniques | 1 | 2007 | 421 | 0.050 |
Why?
| | Methyl Green | 1 | 2003 | 1 | 0.050 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 20 | 0.050 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2003 | 10 | 0.050 |
Why?
| | Colostomy | 3 | 2004 | 28 | 0.050 |
Why?
| | Mast Cells | 1 | 2024 | 147 | 0.050 |
Why?
| | Ascites | 1 | 2003 | 46 | 0.050 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2024 | 191 | 0.050 |
Why?
| | Urine | 1 | 2003 | 59 | 0.050 |
Why?
| | Azo Compounds | 1 | 2003 | 30 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4149 | 0.050 |
Why?
| | Urothelium | 1 | 2003 | 37 | 0.050 |
Why?
| | Pain Threshold | 1 | 2002 | 74 | 0.050 |
Why?
| | Mandelic Acids | 1 | 2002 | 2 | 0.050 |
Why?
| | Urinary Sphincter, Artificial | 1 | 2002 | 4 | 0.050 |
Why?
| | Erectile Dysfunction | 1 | 2022 | 39 | 0.050 |
Why?
| | Puberty | 1 | 2003 | 146 | 0.050 |
Why?
| | Endocrinology | 1 | 2003 | 79 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2007 | 303 | 0.050 |
Why?
| | Observer Variation | 1 | 2003 | 343 | 0.050 |
Why?
| | Oligohydramnios | 1 | 2002 | 12 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2003 | 125 | 0.050 |
Why?
| | Cholinergic Antagonists | 1 | 2002 | 30 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 53 | 0.050 |
Why?
| | Dilatation, Pathologic | 2 | 2001 | 62 | 0.050 |
Why?
| | Pelvic Neoplasms | 1 | 2002 | 26 | 0.050 |
Why?
| | Ureteral Diseases | 1 | 2001 | 3 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3284 | 0.050 |
Why?
| | Blood Pressure | 4 | 1997 | 1786 | 0.050 |
Why?
| | Pulmonary Surfactant-Associated Proteins | 2 | 2000 | 10 | 0.050 |
Why?
| | Proteolipids | 2 | 2000 | 31 | 0.040 |
Why?
| | Learning Curve | 1 | 2022 | 72 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2002 | 238 | 0.040 |
Why?
| | Cysts | 1 | 2002 | 113 | 0.040 |
Why?
| | Urinary Fistula | 1 | 2000 | 9 | 0.040 |
Why?
| | Radiography | 1 | 2003 | 822 | 0.040 |
Why?
| | Adenocarcinoma | 1 | 2007 | 940 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 455 | 0.040 |
Why?
| | Sexual Dysfunctions, Psychological | 1 | 2000 | 34 | 0.040 |
Why?
| | Blotting, Western | 1 | 2003 | 1226 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2024 | 2057 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2023 | 956 | 0.040 |
Why?
| | Jejunal Diseases | 1 | 1999 | 7 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2691 | 0.040 |
Why?
| | Gastric Fistula | 1 | 1999 | 9 | 0.040 |
Why?
| | Intestinal Fistula | 1 | 1999 | 17 | 0.040 |
Why?
| | Actins | 1 | 2002 | 416 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2019 | 8 | 0.040 |
Why?
| | Myosin-Light-Chain Kinase | 1 | 2019 | 20 | 0.040 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 10 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 79 | 0.040 |
Why?
| | Pulmonary Alveoli | 2 | 2000 | 405 | 0.040 |
Why?
| | Digestive System Diseases | 1 | 1998 | 26 | 0.040 |
Why?
| | Pelvis | 1 | 1999 | 102 | 0.040 |
Why?
| | Middle Aged | 6 | 2024 | 33479 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2018 | 21 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 402 | 0.040 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 28 | 0.040 |
Why?
| | Rectal Prolapse | 1 | 2018 | 23 | 0.040 |
Why?
| | Counseling | 1 | 2002 | 391 | 0.040 |
Why?
| | Cecostomy | 1 | 1998 | 3 | 0.040 |
Why?
| | Surgical Stomas | 1 | 1998 | 7 | 0.040 |
Why?
| | Drainage | 1 | 1999 | 173 | 0.040 |
Why?
| | Surgical Mesh | 1 | 1998 | 47 | 0.040 |
Why?
| | Quality of Life | 1 | 2009 | 2892 | 0.030 |
Why?
| | Mutation | 1 | 2009 | 3958 | 0.030 |
Why?
| | Sigmoid Diseases | 1 | 1997 | 12 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2003 | 762 | 0.030 |
Why?
| | Blood Gas Analysis | 1 | 1997 | 74 | 0.030 |
Why?
| | Cardiology Service, Hospital | 1 | 1997 | 24 | 0.030 |
Why?
| | Survival Analysis | 2 | 2017 | 1325 | 0.030 |
Why?
| | Capillaries | 1 | 1998 | 108 | 0.030 |
Why?
| | Ileal Diseases | 1 | 1996 | 13 | 0.030 |
Why?
| | Ampulla of Vater | 1 | 1997 | 42 | 0.030 |
Why?
| | Duodenum | 1 | 1997 | 78 | 0.030 |
Why?
| | Stomach | 1 | 1997 | 110 | 0.030 |
Why?
| | Rhabdomyosarcoma | 1 | 2017 | 72 | 0.030 |
Why?
| | Barrett Esophagus | 1 | 1999 | 149 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 114 | 0.030 |
Why?
| | Rectal Neoplasms | 2 | 1998 | 149 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1272 | 0.030 |
Why?
| | Rats | 2 | 1996 | 5647 | 0.030 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 1995 | 137 | 0.030 |
Why?
| | Umbilical Cord | 1 | 1996 | 85 | 0.030 |
Why?
| | Collagen | 2 | 1995 | 452 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 145 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5472 | 0.030 |
Why?
| | Clinical Protocols | 1 | 1997 | 271 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 686 | 0.030 |
Why?
| | Wound Healing | 1 | 1998 | 331 | 0.030 |
Why?
| | NADPH Dehydrogenase | 1 | 1995 | 7 | 0.030 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 19 | 0.030 |
Why?
| | Tunica Intima | 1 | 1995 | 84 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1759 | 0.030 |
Why?
| | Proteins | 3 | 1995 | 1009 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 33 | 0.030 |
Why?
| | Bupivacaine | 1 | 1994 | 32 | 0.030 |
Why?
| | Swine | 1 | 1996 | 775 | 0.030 |
Why?
| | Thoracotomy | 1 | 1994 | 75 | 0.030 |
Why?
| | United States | 1 | 2011 | 14841 | 0.030 |
Why?
| | Heart Diseases | 1 | 1997 | 346 | 0.030 |
Why?
| | Endothelins | 1 | 1994 | 65 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 622 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7635 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 754 | 0.030 |
Why?
| | Sigmoid Neoplasms | 1 | 1993 | 5 | 0.030 |
Why?
| | Hypertonic Solutions | 1 | 1993 | 7 | 0.030 |
Why?
| | Gangrene | 1 | 1993 | 10 | 0.030 |
Why?
| | Disease Management | 1 | 2017 | 628 | 0.030 |
Why?
| | Product Labeling | 1 | 1993 | 10 | 0.030 |
Why?
| | Ileostomy | 2 | 2004 | 20 | 0.030 |
Why?
| | Recurrence | 1 | 1995 | 1060 | 0.020 |
Why?
| | INDEL Mutation | 1 | 2011 | 16 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2011 | 32 | 0.020 |
Why?
| | Necrosis | 1 | 1993 | 246 | 0.020 |
Why?
| | Consanguinity | 1 | 2011 | 49 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 155 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2011 | 78 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 1997 | 530 | 0.020 |
Why?
| | Colorado | 2 | 2018 | 4565 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 367 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 170 | 0.020 |
Why?
| | Colitis | 1 | 1993 | 266 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2000 | 301 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2013 | 660 | 0.020 |
Why?
| | Aged | 3 | 2024 | 23961 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2181 | 0.020 |
Why?
| | Tissue Survival | 1 | 2007 | 18 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 37 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1995 | 842 | 0.020 |
Why?
| | Chronic Disease | 1 | 1993 | 1793 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2007 | 144 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 100 | 0.020 |
Why?
| | Microsurgery | 1 | 2007 | 75 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 184 | 0.020 |
Why?
| | Vaginal Neoplasms | 1 | 2006 | 18 | 0.020 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2006 | 79 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1570 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 1998 | 1910 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2009 | 1236 | 0.020 |
Why?
| | Hydroxyproline | 2 | 1995 | 21 | 0.020 |
Why?
| | Elastin | 2 | 1995 | 78 | 0.010 |
Why?
| | Duodenal Obstruction | 1 | 2004 | 5 | 0.010 |
Why?
| | Intestinal Atresia | 1 | 2004 | 15 | 0.010 |
Why?
| | Parenteral Nutrition, Total | 1 | 2004 | 26 | 0.010 |
Why?
| | Short Bowel Syndrome | 1 | 2004 | 26 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3015 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3412 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1483 | 0.010 |
Why?
| | Enteritis | 1 | 2004 | 103 | 0.010 |
Why?
| | Gender Identity | 1 | 2003 | 124 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1178 | 0.010 |
Why?
| | Aorta | 2 | 1995 | 417 | 0.010 |
Why?
| | Europe | 1 | 2003 | 414 | 0.010 |
Why?
| | Abdomen | 1 | 2002 | 125 | 0.010 |
Why?
| | Hip Joint | 1 | 2002 | 171 | 0.010 |
Why?
| | Movement | 1 | 2002 | 278 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 985 | 0.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2000 | 106 | 0.010 |
Why?
| | Societies, Medical | 1 | 2003 | 820 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 1043 | 0.010 |
Why?
| | Glycoproteins | 1 | 2000 | 342 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 1998 | 25 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4193 | 0.010 |
Why?
| | Graft Survival | 1 | 2001 | 535 | 0.010 |
Why?
| | DNA | 2 | 1995 | 1459 | 0.010 |
Why?
| | Blood-Air Barrier | 1 | 1998 | 11 | 0.010 |
Why?
| | Leiomyoma | 1 | 1998 | 77 | 0.010 |
Why?
| | Survival Rate | 1 | 2002 | 1972 | 0.010 |
Why?
| | Skin | 1 | 2002 | 752 | 0.010 |
Why?
| | Esophagoscopy | 1 | 1999 | 209 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 202 | 0.010 |
Why?
| | Constriction | 1 | 1996 | 47 | 0.010 |
Why?
| | Venous Thrombosis | 1 | 1998 | 190 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2002 | 570 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1996 | 67 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 1997 | 252 | 0.010 |
Why?
| | Venules | 1 | 1995 | 14 | 0.010 |
Why?
| | Heart Septum | 1 | 1995 | 28 | 0.010 |
Why?
| | Arterioles | 1 | 1995 | 52 | 0.010 |
Why?
| | Biopsy | 1 | 1999 | 1129 | 0.010 |
Why?
| | Heart Septal Defects, Atrial | 1 | 1995 | 54 | 0.010 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1995 | 52 | 0.010 |
Why?
| | Pneumonia | 1 | 2000 | 639 | 0.010 |
Why?
| | Pleura | 1 | 1994 | 23 | 0.010 |
Why?
| | Heart Atria | 1 | 1995 | 137 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 1995 | 240 | 0.010 |
Why?
| | Bronchi | 1 | 1995 | 260 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 752 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1995 | 560 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 1995 | 688 | 0.010 |
Why?
| | Hospital Mortality | 1 | 1997 | 911 | 0.010 |
Why?
| | Heparin | 1 | 1994 | 261 | 0.010 |
Why?
| | Echocardiography | 1 | 1994 | 642 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 788 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1999 | 1114 | 0.000 |
Why?
|
|
Wilcox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|